Blog - Page 45 of 45 - CED Foundation

CBD Eases Recovery Among Heroin Abusers

May 28, 2019 CBD, Opiates

Cannabidiol (CBD) demonstrates a reduction in cue-induced heroin cravings and anxiety levels for those affected by heroin use disorder. In a study conducted at Mount Sinai hospital, former heroin abusers were treated with placebo, a low level of CBD, or a high level of CBD. Individuals who received either amount of CBD displayed fewer cravings in response to drug cues in the hours after administration, with those receiving the higher amount of CBD experiencing the lowest levels of craving one week after treatment. Participants treated with either amount of CBD exhibited significantly lower anxiety levels than the placebo group. CBD could be a viable treatment option for those suffering from heroin use disorder.

CED Foundation Google Drive: http://bit.ly/30AWkcH

Read Here or Download:

Cannabidiol for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial Download

CBD Can Mitigate Anxiety in Fragile X Patients

May 28, 2019 Anxiety, CBD, Fragile X

#CBD reduces anxiety levels not just in neurotypical users, but also with patients suffering from #FragileX

Individuals suffering from the neurodevelopmental disorder Fragile X Syndrome experience many symptoms mimicking those of autism, including increased anxiety. To investigate the effects of cannabidiol (CBD) on Fragile X symptom mitigation, a mouse model possessing the DNA mutations which give rise to Fragile X was treated with CBD. CBD treatment was shown to reduce anxiety in both affected and non-affected mice while preserving locomotive, social, and cognitive performance. Future studies exploring CBD as treatment for Fragile X may reveal other benefits.

http://bit.ly/30REcew

Terpenes rising in popularity

May 28, 2019 Cannabis News

Terpenes are starting to be recognized for their value add to #cannabis, & we are seeing a rise in terpene-based products & consumables. Companies offering terpenes in essential oils & products such as the Pulsar Rok to experience them to their fullest. http://bit.ly/2VRTX1u

CBD May Have Potential for Hepatocellular Carcinoma Treatment

May 28, 2019 Cancer, CBD

Additional research may show potential for CBD as a therapeutic agent for hepatocellular carcinoma

Cannabinoid (CBD) may be an effective treatment for hepatocellular carcinoma (HCC). Cannabinoid receptor 2 (CB2 receptor) has demonstrated anti-tumor behavior in other tumor types. In a new study, HCC cells treated with MDA19, a molecule that binds to the CB2 receptor, grew more slowly than untreated cells. With CBD also binding to the CB2 receptor, there may be precedent for research on the potential of CBD as a treatment for HCC.

CED Foundation Google Drive: http://bit.ly/2YRTyhl

Read Here or Download:

MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway Download

Cannabis Reduces Tumor Growth and Symptoms in Breast Cancer Patients

May 28, 2019 Uncategorized

Breast cancer patients can use medical cannabis to manage symptoms and slow cancer growth

Cannabidiol (CBD) and tetrahydrocannabinol (THC) can be used to both mitigate the symptoms of breast cancer and slow tumor growth. Both cannabis components are active against estrogen-resistant breast cancer cells and reduce disease progression by inhibiting the cell cycle and inducing death in cancer cells. Cannabis is already used to treat late-stage breast cancer, but with additional research, could also have therapeutic potential at earlier stages.

CED Foundation Google Drive: http://bit.ly/2YQZqHG

Read Here or Download:

Future Aspects for Cannabinoids in Breast Cancer Therapy Download

Cannabis Components Prevent Neurodegeneration Observed in Alzheimer’s

May 28, 2019 Alzheimer's Disease

At least 9 #cannabis components may prevent the neurodegeneration observed in #Alzheimer’s patients.

Certain cannabis components may have therapeutic potential for Alzheimer’s Disease treatment. In an analysis of eleven cannabis components, nine components protected human cells from the neurodegeneration characteristic to Alzheimer’s. Further research could shed light on the capabilities of these components with respect to Alzheimer’s treatment.

CED Foundation Google Drive: http://bit.ly/2HHpAH0

Read Here or Download:

Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease
Download

CBD Could be Subject to Further Research for IBS Therapy

May 28, 2019 CBD, IBS

Cannabis may be an effective treatment for Irritable Bowel Syndrome (IBS). cannabinoid receptor 2 (CB2), responsible for binding cannabidiol (CBD) and producing many of its known effects, can relieve many symptoms if IBS after activation by an “agonist” or binding partner. In rat models mimicking IBS, the presence of a CB2 receptor agonist decreased colonic hypermotility, a debilitating symptom of IBS. As CBD is an agonist of CB2, therapeutic innovations for IBS using cannabis may be possible.

CED Foundation Google Drive: http://bit.ly/2HHM8HF
Read Here or Download:

Cannabinoid‐induced relief of hypermotility in a rat model of the irritable bowel syndrome Download